1-9 of 9
Authors: Yoshihiro Otani
Journal Article
ACCEPTED MANUSCRIPT
Brain CD73 modulates interferon signaling to regulate glioblastoma invasion Open Access
Neuro-Oncology Advances, vdaf080, https://doi.org/10.1093/noajnl/vdaf080
Published: 24 April 2025
Journal Article
Evaluating short-term survivors of glioblastoma: A proposal based on SEER registry data Open Access
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf036, https://doi.org/10.1093/noajnl/vdaf036
Published: 09 February 2025
Journal Article
10110- COT-11 EVALUATING SHORT-TERM SURVIVORS OF GLIOBLASTOMA: A PROPOSAL BASED ON SEER REGISTRY DATA Open Access
Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Pages iv25–iv26, https://doi.org/10.1093/noajnl/vdae173.100
Published: 29 November 2024
Journal Article
10166- ACT-9 TRANSLATING BASIC RESEARCH ON AD-REIC FOR RECURRENT GLIOBLASTOMA INTO AN INVESTIGATOR-INITIATED CLINICAL TRIAL Open Access
Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Page iv8, https://doi.org/10.1093/noajnl/vdae173.030
Published: 29 November 2024
Journal Article
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study Open Access
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae176, https://doi.org/10.1093/noajnl/vdae176
Published: 28 November 2024
Journal Article
10036-IM-3 SPATIAL AND GENOMIC ANALYSES FOR THE CONSTRUCTION OF TERTIARY LYMPHOID STRUCTURE IN GLIOBLASTOMA Open Access
Neuro-Oncology Advances, Volume 5, Issue Supplement_5, December 2023, Pages v5–v6, https://doi.org/10.1093/noajnl/vdad141.020
Published: 10 December 2023
Journal Article
10038-ANGI-2 NEW ANTI-ANGIOGENIC THERAPY WITH THE ANTI-DEPRESSANT TOWARD TUMOR DERIVED ENDOTHELIAL CELLS (TDECS) Open Access
Neuro-Oncology Advances, Volume 5, Issue Supplement_5, December 2023, Page v6, https://doi.org/10.1093/noajnl/vdad141.022
Published: 10 December 2023
Journal Article
Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib Open Access
Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac095, https://doi.org/10.1093/noajnl/vdac095
Published: 20 June 2022
Journal Article
Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion Open Access
Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac094, https://doi.org/10.1093/noajnl/vdac094
Published: 13 June 2022
